Search Results 301-310 of 10033 for younkin
About this study. This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of ...
About this study. This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation ...
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES).
Part 1a will evaluate a JAK inhibitor with JAK1 selectivity (INCB039110) in combination with an IDO1 inhibitor (epacadostat; INCB024360; Group A) and INCB039110 ...
The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function when using QPI-1002 with kidney transplants from ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary objective of the study is to compare sacituzumab tirumotecan combined with ...
Jannetto PJ, Langman LJ. High-throughput online solid-phase extraction tandem mass spectrometry: Is it right for your clinical laboratory? Clin Biochem. 2016 ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Can pericranium be used to regrow bone for the repair of critical mandibular defects? Participation eligibility. Participant eligibility includes age, gender, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.